494
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Examining Health Promotion Theories, Limitations, and Lessons Learned for HPV Vaccination Interventions among College Students in the United States: A Systematic Literature Review

ORCID Icon, , , &
Pages 179-197 | Received 18 Nov 2022, Accepted 13 Dec 2022, Published online: 10 Apr 2023

References

  • Lewis RM, Laprise JF, Gargano JW, et al. Estimated prevalence and incidence of disease-associated human Papillomavirus types among 15- to 59-year-Olds in the United States. Sex Transm Dis. 2021;48(4):273–277.doi:10.1097/OLQ.0000000000001356.
  • Owusu-Edusei K Jr, Chesson HW, Gift TL, et al. The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008. Sex Transm Dis. 2013;40(3):197–201.doi:10.1097/OLQ.0b013e318285c6d2.
  • Reproductive cancers. Hhs.gov. https://opa.hhs.gov/reproductive-health/reproductive-cancers. Accessed November 21, 2022.
  • Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4(9):e609–16. doi:10.1016/S2214-109X(16)30143-7.
  • Luciani S, Bruni L, Agurto I, Ruiz-Matus C. HPV vaccine implementation and monitoring in Latin America. Salud Publica Mex. 2018;60(6):683–692. doi:10.21149/9090.
  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492.
  • de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13(6):607–615.doi:10.1016/S1470-2045(12)70137-7.
  • Forman D, de Martel C, Lacey CJ, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30(Suppl 5):F12–23.doi:10.1016/j.vaccine.2012.07.055.
  • Buchanan TR, Graybill WS, Pierce JY. Morbidity and mortality of vulvar and vaginal cancers: impact of 2-, 4-, and 9-valent HPV vaccines. Hum Vaccin Immunother. 2016;12(6):1352–1356. doi:10.1080/21645515.2016.1147634.
  • Bruggink SC, de Koning MNC, Gussekloo J, et al. Cutaneous wart-associated HPV types: prevalence and relation with patient characteristics. J Clin Virol. 2012;55(3):250–255.doi:10.1016/j.jcv.2012.07.014.
  • Gissmann L, Wolnik L, Ikenberg H, Koldovsky U, Schnürch HG, Zur Hausen H. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Nat Acad Sci U S A. 1983;80:560–563. doi:10.1073/pnas.80.2.560.
  • Markowitz LE, Dunne EF, Saraiya M, et al. Human Papillomavirus Vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Recommendations and Reports: Morbidity and Mortality Weekly Report. Recommendations and Reports. Vol. 63. Washington, DC: CDC; 2014.
  • Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–19. doi:10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.
  • Gerend MA, Shepherd JE. Predicting human papillomavirus vaccine uptake in young adult women: comparing the health belief model and theory of planned behavior. Ann Behav Med. 2012;44(2):171–180. doi:10.1007/s12160-012-9366-5.
  • Jain A, Barone M. Preventing cervical cancer. AVSC News. 1996;34(3):2. PMID: 12347474.
  • Slater JS, Bar-Cohen A, Korn JE, Yawn B. Preventing cervical cancer. Minn Med. 1994;77(5):25–26.
  • Juraskova I, Bari RA, O’Brien MT, McCaffery KJ. HPV vaccine promotion: does referring to both cervical cancer and genital warts affect intended and actual vaccination behavior? Womens Health Issues. 2011;21(1):71–79. doi:10.1016/j.whi.2010.08.004.
  • Patel DA, Zochowski M, Peterman S, Dempsey AF, Ernst S, Dalton VK. Human papillomavirus vaccine intent and uptake among female college students. J Am Coll Health. 2012;60(2):151–161. doi:10.1080/07448481.2011.580028.
  • Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR. Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis. 2006;194(8):1044–1057. doi:10.1086/507432.
  • Saraiya M, Unger ER, Thompson TD, et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst. 2015;107(6):djv086.doi:10.1093/jnci/djv086.
  • Colón-López V, Ortiz AP, Palefsky J. Burden of human papillomavirus infection and related comorbidities in men: implications for research, disease prevention and health promotion among Hispanic men. P R Health Sci J. 2010;29:232–240.
  • Giuliano AR, Lazcano-Ponce E, Villa LL, et al. The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev. 2008;17(8):2036–2043.doi:10.1158/1055-9965.EPI-08-0151.
  • Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294–4301.doi:10.1200/JCO.2011.36.4596.
  • Van Dyne EA, Henley SJ, Saraiya M, Thomas CC, Markowitz LE, Benard VB. Trends in human Papillomavirus-associated cancers - United States, 1999–2015. MMWR Morb Mortal Wkly Rep. 2018;67(33):918–924. doi:10.15585/mmwr.mm6733a2.
  • McNamara M, Batur P, Walsh JME, Johnson KM. HPV update: vaccination, screening, and associated disease. J Gen Intern Med. 2016;31(11):1360–1366. doi:10.1007/s11606-016-3725-z.
  • Yu Y, Guo J, Li D, Liu Y, Yu Y, Wang L. Development of a human papillomavirus type 6/11 vaccine candidate for the prevention of condyloma acuminatum. Vaccine. 2018;36(32):4927–4934. doi:10.1016/j.vaccine.2018.06.041.
  • Centers for Disease Control and Prevention (CDC). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010;59(20): 626–629.
  • Gee J, Weinbaum C, Sukumaran L, Markowitz LE. Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States. Hum Vaccin Immunother. 2016;12(6):1406–1417. doi:10.1080/21645515.2016.1168952.
  • Rossi C, Laurent VC. Vaccination contre le papillomavirus humain (HPV) chez les garçons et les hommes: actualités et recommandations [HPV vaccination in boys and men: update and recommendations. Rev Med Brux. 2018;39(4):352–358. PMID: 30321000.
  • Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination - updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2016;65(49):1405–1408. doi:10.15585/mmwr.mm6549a5.
  • Alonso S, Cambaco O, Maússe Y, et al. Costs associated with delivering HPV vaccination in the context of the first year demonstration programme in southern Mozambique. BMC Public Health. 2019;19(1):1031.doi:10.1186/s12889-019-7338-4.
  • Thompson EL, Vamos CA, Vázquez-Otero C, Logan R, Griner S, Daley EM. Trends and predictors of HPV vaccination among U.S. College women and men. Prev Med. 2016;86:92–98. doi:10.1016/j.ypmed.2016.02.003.
  • Licht AS, Murphy JM, Hyland AJ, Fix BV, Hawk LW, Mahoney MC. Is use of the human papillomavirus vaccine among female college students related to human papillomavirus knowledge and risk perception? Sex Transm Infect. 2010;86(1):74–78. doi:10.1136/sti.2009.037705.
  • Revzina NV, Diclemente RJ. Prevalence and incidence of human papillomavirus infection in women in the USA: a systematic review. Int J STD AIDS. 2005;16(8):528–537. doi:10.1258/0956462054679214.
  • Cinar İO, Ozkan S, Aslan GK, Alatas E. Knowledge and behavior of university students toward human Papillomavirus and vaccination. Asia Pac J Oncol Nurs. 2019;6(3):300–307. doi:10.4103/apjon.apjon_10_19.
  • McLendon L, Puckett J, Green C, et al. Factors associated with HPV vaccination initiation among United States college students. Hum Vaccin Immunother. 2021;17(4):1033–1043.doi:10.1080/21645515.2020.1847583.
  • Sandfort JR, Pleasant A. Knowledge, attitudes, and informational behaviors of college students in regard to the human papillomavirus. J Am Coll Health. 2009;58(2):141–149. doi:10.1080/07448480903221368.
  • Gerend MA, Magloire ZF. Awareness, knowledge, and beliefs about human papillomavirus in a racially diverse sample of young adults. J Adolesc Health. 2008;42(3):237–242. doi:10.1016/j.jadohealth.2007.08.022.
  • Barnard M, Cole AC, Ward L, Gravlee E, Cole ML, Compretta C. Interventions to increase uptake of the human papillomavirus vaccine in unvaccinated college students: a systematic literature review. Prev Med Rep. 2019;14(100884):100884. doi:10.1016/j.pmedr.2019.100884.
  • Kellogg C, Shu J, Arroyo A, et al. A significant portion of college students are not aware of HPV disease and HPV vaccine recommendations. Hum Vaccin Immunother. 2019;15(7–8):1760–1766.doi:10.1080/21645515.2019.1627819.
  • Barnard M, George P, Perryman ML, Wolff LA, De Groot AS. Human papillomavirus (HPV) vaccine knowledge, attitudes, and uptake in college students: implications from the Precaution Adoption Process Model. PLoS One. 2017;12(8):e0182266. doi:10.1371/journal.pone.0182266.
  • Richman AR, Maddy L, Torres E, Goldberg EJ. A randomized intervention study to evaluate whether electronic messaging can increase human papillomavirus vaccine completion and knowledge among college students. J Am Coll Health. 2016;64(4):269–278. doi:10.1080/07448481.2015.1117466.
  • Fu LY, Bonhomme LA, Cooper SC, Joseph JG, Zimet GD. Educational interventions to increase HPV vaccination acceptance: a systematic review. Vaccine. 2014;32(17):1901–1920. doi:10.1016/j.vaccine.2014.01.091.
  • Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for Systematic Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–473.doi:10.7326/M18-0850.
  • Arksey H, O’Malley L. Systematic studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32. doi:10.1080/1364557032000119616.
  • Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Syst Rev. 2016;5:1. doi:10.1186/s13643-016-0384-4.
  • Office of the Assistant Secretary for Health (OASH). HHS announces new HPV vaccination campaign for young adults and Health care providers. US Department of Health and Human Services. https://www.hhs.gov/about/news/2021/01/06/hhs-announces-new-hpv-vaccination-campaign-young-adults-health-care-providers.html. Published January 6, 2021. Accessed November 21, 2022.
  • Wong LP, Alias H, Wong PF, Lee HY, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vaccin Immunother. 2020;16(9):2204–2214. doi:10.1080/21645515.2020.1790279.
  • Zampetakis LA, Melas C. The health belief model predicts vaccination intentions against COVID-19: a survey experiment approach. Appl Psychol Health Well Being. 2021;13(2):469–484. doi:10.1111/aphw.12262.
  • Genevieve O Development and evaluation of a theory-informed, culturally specific educational human Papillomavirus (HPV) vaccine comic book for college students in Northeast Ohio: an Application of the Integrated Behavior Model (IBM) [Dissertation]. Kent State University; 2018.
  • Bennett AT, Patel DA, Carlos RC, et al. Human Papillomavirus vaccine uptake after a tailored, online educational intervention for female university students: a randomized controlled trial. J Womens Health (Larchmt). 2015;24(11):950–957.doi:10.1089/jwh.2015.5251.
  • Brandt HM, Sundstrom B, Monroe CM, et al. Evaluating a technology-mediated HPV vaccination awareness intervention: a controlled, quasi-experimental mixed methods study. Vaccines (Basel). 2020;8(4):749.doi:10.3390/vaccines8040749.
  • Daly KL, Halon PA, Aronowitz T, Ross G. A university health initiative to increase human Papillomavirus vaccination rates. J Nurse Pract. 2016;12(6):e281–e286. doi:10.1016/j.nurpra.2016.02.013.
  • Darville- Sanders GC, MacInnes J, Schwarz K. “Someone You Love” documentary: using narratives in entertainment media to increase HPV vaccination in Georgia. J Ga Public Health Assoc. 2022;8(3). doi:10.20429/jgpha.2022.080306.
  • Gerend MA, Murdock C, Grove K. An intervention for increasing HPV vaccination on a university campus. Vaccine. 2020;38(4):725–729. doi:10.1016/j.vaccine.2019.11.028.
  • Gross MS, Tran CH, Sutherland KH, Castagno JC, Amdur RJ. Pilot study: can an educational intervention increase human Papillomavirus vaccination in female college students? Obstet Gynecol. 2014;123(Supplement1):114S–115S. doi:10.1097/01.aog.0000447062.94587.52.
  • Hayes KN, Pan I, Kunkel A, McGivney MS, Thorpe CT. Evaluation of targeted human papillomavirus vaccination education among undergraduate college students. J Am Coll Health. 2019;67(8):781–789. doi:10.1080/07448481.2018.1515742.
  • Hopfer S. Effects of a narrative HPV vaccination intervention aimed at reaching college women: a randomized controlled trial. Prev Sci. 2012;13(2):173–182. doi:10.1007/s11121-011-0254-1.
  • Kim M, Lee H, Kiang P, et al. A storytelling intervention in a mobile, Web-based platform: a pilot randomized controlled trial to evaluate the preliminary effectiveness to promote human Papillomavirus vaccination in Korean American college women. Health Educ Behav. 2020;47(2):258–263.doi:10.1177/1090198119894589.
  • Long AG, Roberts CM, Hayney MS. Pharmacy student involvement with increasing human papillomavirus (HPV) vaccination among international college students. J Am Pharm Assoc (2003). 2017;57(1):127–128. doi:10.1016/j.japh.2016.11.009.
  • Martin S, Warner EL, Kirchhoff AC, Mooney R, Martel L, Kepka D. An electronic medical record alert intervention to improve HPV vaccination among eligible male college students at a university student health center. J Community Health. 2018;43(4):756–760. doi:10.1007/s10900-018-0480-6.
  • Mehta P, Sharma M, Lee RC. Designing and evaluating a health belief model-based intervention to increase intent of HPV vaccination among college males. Int Q Community Health Educ. 2013;34(1):101–117. doi:10.2190/IQ.34.1.h.
  • Nan X, Dahlstrom MF, Richards A, Rangarajan S. Influence of evidence type and narrative type on HPV risk perception and intention to obtain the HPV vaccine. Health Commun. 2015;30(3):301–308. doi:10.1080/10410236.2014.888629.
  • Paiva AL, Lipschitz JM, Fernandez AC, Redding CA, Prochaska JO. Evaluation of the acceptability and feasibility of a computer-tailored intervention to increase human papillomavirus vaccination among young adult women. J Am Coll Health. 2014;62(1):32–38. doi:10.1080/07448481.2013.843534.
  • Perez G, Cruess DG, Strauss N. A brief information–motivation–behavioral skills intervention to promote human papillomavirus vaccination among college-aged women. Psychol Res Behav Manag. 2016;9:285–296. doi:10.2147/prbm.s112504.
  • Staples JN, Wong MS, Rimel BJ. An educational intervention to improve human papilloma virus (HPV) and cervical cancer knowledge among African American college students. Gynecol Oncol. 2018;149(1):101–105. doi:10.1016/j.ygyno.2017.10.015.
  • Yahia A, Cole E, Rayford A, Fava J. A community-based, interdisciplinary approach to improving HPV vaccine uptake at a large urban public university. J Am Coll Health. 2022;1–7. Published online doi:10.1080/07448481.2022.2044823.
  • Walker TY, Elam-Evans LD, Singleton JA, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years — United States, 2016. MMWR Morb Mortal Wkly Rep. 2017;66(33):874–882. doi:10.15585/mmwr.mm6633a2.
  • Austin JD, Rodriguez SA, Savas LS, Megdal T, Ramondetta L, Fernandez ME. Using Intervention Mapping to develop a provider intervention to increase HPV vaccination in a Federally Qualified Health Center. Front Public Health. 2020;8:530596. doi:10.3389/fpubh.2020.530596.
  • Leung SOA, Akinwunmi B, Elias KM, Feldman S. Educating healthcare providers to increase Human Papillomavirus (HPV) vaccination rates: a qualitative systematic review. Vaccine X. 2019;3(100037):100037. doi:10.1016/j.jvacx.2019.100037.
  • Dempsey AF, Pyrzanowski J, Campagna EJ, Lockhart S, O’Leary ST. Parent report of provider HPV vaccine communication strategies used during a randomized, controlled trial of a provider communication intervention. Vaccine. 2019;37(10):1307–1312. doi:10.1016/j.vaccine.2019.01.051.
  • Holloway GL. Effective HPV vaccination strategies: what does the evidence say? An integrated literature review. J Pediatr Nurs. 2019;44:31–41. doi:10.1016/j.pedn.2018.10.006.
  • Lourida I, Abbott RA, Rogers M, et al. Dissemination and implementation research in dementia care: a systematic review and evidence map. BMC Geriatr. 2017;17:1. doi:10.1186/s12877-017-0528-y.
  • Areas of responsibility, competencies and sub-competencies for health education specialist practice analysis in 2020 (HESPA II 2020). Speakcdn.com. https://assets.speakcdn.com/assets/2251/hespa_competencies_and_sub-competencies_052020.pdf. Accessed December 12, 2022.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.